<DOC>
	<DOCNO>NCT01411735</DOCNO>
	<brief_summary>BACKGROUND : Exercise intolerance primary symptom old patient heart failure preserve ejection fraction ( HFPEF ) , however little known regard mechanisms therapy . METHODS : 71 elderly stable , compensated HFPEF patient ( age 70+1 year ; 80 % woman ) control blood pressure randomize 12 month follow-up ( FU ) double-blind trial enalapril 20 mg per day ( E ) vs. placebo ( P ) . Assessments include : peak exercise oxygen consumption ( VO2 ) ; six-minute walk test ; Minnesota Living HF Questionnaire ( MLHF ) ; MRI ; Doppler-echocardiography ; vascular ultrasound .</brief_summary>
	<brief_title>Evaluation Enalapril Versus Placebo Patients With Diastolic Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Heart Failure , Diastolic</mesh_term>
	<mesh_term>Enalapril</mesh_term>
	<mesh_term>Enalaprilat</mesh_term>
	<criteria>All participant 60 year age old . 1. systolic dysfunction 2. patient evidence significant ischemic valvular heart disease 3. chronic pulmonary disease . Participants appear preliminarily eligible invite formal screening visit investigator cardiology physician . They also undergo rest exercise electrocardiogram echocardiogram pulmonary function test well blood hematology chemistry test . Final eligibility base upon information available conclusion screen visit test , include hospital outpatient record , history , physical examination , echocardiogram exercise test .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>